Delivery Order SPE2DB20D2104-SPE2DB24FV16T

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.36 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.59, is a Firm Fixed Price Delivery Order for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and was awarded on January 22, 2024. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $2,303.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. This is a firm fixed price delivery order contract with a period of performance ending on February 21, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,438.01 firm fixed-price delivery order is for "LOW-OGESTREL-28 TABLET 28S", a generic contraceptive medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for the...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FT41H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,840.19 delivery order contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a period of performance through May 9, 2023. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug product "LOW-OGESTREL-28 TABLET 28S" and has a ceiling value of $2,427.87. The contract was awarded on October 28, 2024, with a completion date of October 29, 2024, and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,370.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563969966 LOW-OGESTREL-28 TABLET 28S. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $5,600.20 firm fixed-price contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a prescription medication, with a completion date of May 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31,...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHQ13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,412.97 delivery order contract is for the supply of the pharmaceutical product LOW-OGESTREL-28 TABLET 28S. The contract has a firm-fixed price pricing type and an ultimate completion date of June 6, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,330.21, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, worth $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV16T
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.84 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a completion date of July 15, 2024.

The award is not designated as a set-aside contract. It is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

Generated 2/27/25, 11:42 AM